Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute

Bone

Volumn 38, Issue 3, 2006, Pages 432-443

  Välimäki, Ville Valtteri ^a   Moritz, Niko ^a   Yrjans, Jessica J ^a   Vuorio, Eero ^a   Aro, Hannu T ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bioactive glass; Bone graft substitutes; Doxycycline; Zoledronic acid

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BISPHOSPHONIC ACID DERIVATIVE; CATHEPSIN K; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; COLLAGENASE 3; DOXIMYCIN; DOXYCYCLINE; GELATINASE B; MESSENGER RNA; METALLOPROTEINASE INHIBITOR; MICROSPHERE; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; SILICON DIOXIDE; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE GRAFT; BONE REMODELING; BONE TURNOVER; CERAMIC PROSTHESIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGITAL RADIOGRAPHY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; FRACTURE HEALING; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; RAT; SCANNING ELECTRON MICROSCOPY; STRESS STRAIN RELATIONSHIP; X RAY ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; BONE SUBSTITUTES; CERAMICS; DENSITOMETRY, X-RAY; DIPHOSPHONATES; DOXYCYCLINE; FEMALE; FOLLOW-UP STUDIES; IMIDAZOLES; MICROSPHERES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIBIA; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 32844472253     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.09.016     Document Type: Article

References (61)

1. S. Larsson, and T.W. Bauer Use of injectable calcium phosphate cement for fracture fixation: a review Clin. Orthop. Relat. Res. 395 2002 23 32
2. J.F. Keating, and M.M. McQueen Substitutes for autologous bone graft in orthopaedic trauma J. Bone Jt. Surg. Br. 83 2001 3 8
3. C.G. Finkemeier Bone-grafting and bone-graft substitutes J. Bone Jt. Surg. Am. 84 2002 454 464
4. L.L. Hench, R.J. Splinter, W.C. Allen, and T.K. Greenlee Bonding mechanisms at the interface of ceramic prosthetic materials J. Biomed. Mater. Res. Symp. 2 1971 117 141
5. 2 J. Biomed. Mater. Res. 37 1997 114 121
6. L.L. Hench, and J.K. West Biological applications of bioactive glasses Life Chem. Rep. 13 1996 187 241
7. P. Ducheyne, and Q. Qiu Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function Biomaterials 20 1999 2287 2303
8. L.L. Hench, and J. Wilson Surface-active biomaterials Science 226 1984 630 636
9. A. El-Ghannam, P. Ducheyne, and I.M. Shapiro Effect of serum proteins on osteoblast adhesion to surface-modified bioactive glass and hydroxyapatite J. Orthop. Res. 17 1999 340 345
10. S. Radin, G. Reilly, G. Bhargave, P.S. Leboy, and P. Ducheyne Osteogenic effects of bioactive glass on bone marrow stromal cells J. Biomed. Mater. Res. 73 2005 21 29
11. C. Loty, J.M. Sautier, M.T. Tan, M. Oboeuf, E. Jallot, and H. Boulekbache Bioactive glass stimulates in vitro osteoblast differentiation and creates a favorable template for bone tissue formation J. Bone Miner. Res. 16 2001 231 239
12. M. Bosetti, and M. Cannas The effect of bioactive glasses on bone marrow stromal cells differentiation Biomaterials 26 2005 3873 3879
13. I.D. Xynos, M.V. Hukkanen, J.J. Batten, L.D. Buttery, L.L. Hench, and J.M. Polak Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering Calcif. Tissue Int. 67 2000 321 329
14. C.D. Morris, and T.A. Einhorn Bisphosphonates in orthopaedic surgery J. Bone Jt. Surg. Am. 87 2005 1609 1618
15. G.D. Roodman, and J.J. Windle Paget disease of bone J. Clin. Invest. 115 2005 200 208
16. S.H. Ralston, R. Coleman, W.D. Fraser, S.J. Gallagher, D.J. Hosking, and J.S. Iqbal Medical management of hypercalcemia Calcif. Tissue Int. 74 2004 1 11
17. M.C. Gainford, G. Dranitsaris, and M. Clemons Recent developments in bisphosphonates for patients with metastatic breast cancer BMJ 330 2005 769 773
18. S.J. Kim, H. Uehara, S. Yazici, J. He, R.R. Langley, and P. Mathew Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer Cancer Res. 65 2005 3707 3715
19. I.R. Reid, J.P. Brown, P. Burckhardt, Z. Horowitz, P. Richardson, and U. Trechsel Intravenous zoledronic acid in postmenopausal women with low bone mineral density N. Engl. J. Med. 346 2002 653 661
20. H.G. Bone, D. Hosking, J.P. Devogelaer, J.R. Tucci, R.D. Emkey, and R.P. Tonino Ten years' experience with alendronate for osteoporosis in postmenopausal women N. Engl. J. Med. 18 2004 1189 1199
21. Fleisch H, Reszka A, Rodan GA, Rogers M, Bisphosphonates: mechanisms of action. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego, CA: Academic Press; 2002. p. 136, 1385.
22. C.P. Peter, W.O. Cook, D.M. Nunamaker, M.T. Provost, J.G. Seedor, and G.A. Rodan Effect of alendronate on fracture healing and bone remodeling in dogs J. Orthop. Res. 14 1996 74 79
23. J.E. Madsen, T. Berg-Larsen, O.J. Kirkeby, J.A. Falch, and L. Nordsletten No adverse effects of clodronate on fracture healing in rats Acta Orthop. Scand. 69 1998 532 536
24. J. Li, S. Mori, Y. Kaji, T. Mashiba, J. Kawanishi, and H. Norimatsu Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats J. Bone Miner. Res. 14 1999 969 979
25. J. Li, S. Mori, Y. Kaji, J. Kawanishi, T. Akiyama, and H. Norimatsu Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats J. Bone Miner. Res. 15 2000 2042 2051
26. C. Li, S. Mori, J. Li, Y. Kaji, T. Akiyama, and J. Kawanishi Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats J. Bone Miner. Res. 16 2001 429 436
27. E. van der Poest Clement, P. Patka, K. Vandormael, H. Haarman, and P. Lips The effect of alendronate on bone mass after distal forearm fracture J. Bone Miner. Res. 15 2000 586 593
28. E. van der Poest Clement, M. van Engeland, H. Ader, J.C. Roos, P. Patka, and P. Lips Alendronate in the prevention of bone loss after a fracture of the lower leg J. Bone Miner. Res. 17 2002 2247 2255
29. A. Koivukangas, J. Tuukkanen, K. Kippo, T. Jämsä, R. Hannuniemi, and I. Pasanen Long-term administration of clodronate does not prevent fracture healing in rats Clin. Orthop. Relat. Res. 408 2003 268 278
30. D.G. Little, N.C. Smith, P.R. Williams, J.N. Briody, L.E. Bilston, and E.J. Smith Zoledronic acid prevents osteopenia and increases bone strength in a rabbit model of distraction osteogenesis J. Bone Miner. Res. 18 2003 1300 1307
31. N. Amanat, R. Brown, L.E. Bilston, and D.G. Little A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair J. Orthop. Res. 23 2005 1029 1034
32. M.M. McDonald, S.K. Dulai, and D.G. Little Zoledronic acid treatment does not delay the process of endochondral ossification in a rat fracture model ASBMR 26th Annual Meeting Abstract SU443 2004
33. J.D. Bobyn, S.A. Hacking, J.J. Krygier, E.J. Harvey, D.G. Little, and M. Tanzer Zoledronic acid causes enhancement of bone growth into porous implants J. Bone Jt. Surg. Br. 87 2005 416 420
34. B. Peter, D.P. Pioletti, S. Laib, B. Bujoli, P. Pilet, and P. Janvier Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration Bone 36 2005 52 60
35. M. Bhandari, S. Bajammal, G.H. Guyatt, L. Griffith, J.W. Busse, and H. Schunemann Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty, a meta-analysis J. Bone Jt. Surg. Am. 87 2005 293 301
36. V.-V. Välimäki, J.J. Yrjans, E. Vuorio, and H.T. Aro Molecular biological evaluation of adjunct treatment with BMP-2 gene transfer and bioactive glass microspheres in enhancement of new bone formation Tissue Eng. 11 2005 387 394
37. V. Pitkänen, J. Tikkanen, M. Paajanen, G. Graeffe, M. Brink, and K.H. Karlsson Processing of spherical bioactive glass particles J. Aerosol Sci. 26 1995 S831 S832
38. L.J. Suva, J.G. Seedor, N. Endo, H.A. Quartuccio, D.D. Thompson, and I. Bab Pattern of gene expression following rat tibial marrow ablation J. Bone Miner. Res. 8 1993 379 388
39. C.T. Liang, J. Barnes, J.G. Seedor, H.A. Quartuccio, M. Bolander, and J.J. Jeffrey Impaired bone activity in aged rats: alterations at the cellular and molecular levels Bone 13 1992 435 441
40. A. Itälä, V.V. Välimäki, R. Kiviranta, H.O. Ylänen, M. Hupa, and E. Vuorio Molecular biologic comparison of new bone formation and resorption on microrough and smooth bioactive glass microspheres J. Biomed. Mater. Res. 65B 2003 163 170
41. V.V. Välimäki, N. Moritz, J.J. Yrjans, M. Dalstra, and H.T. Aro Peripheral quantitative computed tomography in evaluation of bioactive glass incorporation with bone Biomaterials 26 2005 6693 6703
42. Ferretti JL, Peripheral quantitative computed tomography for evaluating structural and mechanical properties of small bone. In: An YH, Draughn RA, editors. Mechanical testing of bone and the bone-implant interface. Boca Raton, FL: CRC Press LLC; 2000. p. 385, 405.
43. J.M. Chirgwin, A.E. Przybyla, R.J. MacDonald, and W.J. Rutter Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease Biochemistry 18 1979 5294 5299
44. M. Metsäranta, D. Toman, B. De Crombrugghe, and E. Vuorio Specific hybridization probes for mouse I type II III and IX collagen mRNAs Biochim. Biophys. Acta 1089 1991 241 243
45. J. Rantakokko, H. Uusitalo, T. Jämsä, J. Tuukkanen, H.T. Aro, and E. Vuorio Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model J. Bone Miner. Res. 14 1999 1934 1942
46. M.F. Young, A.A. Day, P. Dominquez, C.I. McQuillan, L.W. Fisher, and J.D. Termine Structure and expression of osteonectin mRNA in human tissue Connect. Tissue Res. 24 1990 17 28
47. P. Reponen, C. Sahlberg, C. Munaut, I. Thesleff, and K. Tryggvason High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development J. Cell Biol. 124 1994 1091 1102
48. H.J. Salminen, A.M. Säämänen, M.N. Vankemmelbeke, P.K. Auho, M.P. Perälä, and E.I. Vuorio Differential expression patterns of matrix metalloproteinases and their inhibitors during development of osteoarthritis in a transgenic mouse model Ann. Rheum. Dis. 61 2002 591 597
49. J. Rantakokko, H.T. Aro, M. Savontaus, and E. Vuorio Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development FEBS Lett. 393 1996 307 313
50. S.V. Reddy, T. Scarcez, J.J. Windle, R.J. Leach, J.E. Hundley, and J.M. Chirgwin Cloning and characterization of the 5′-flanking region of the mouse tartrate-resistant acid phosphatase gene J. Bone Miner. Res. 8 1993 1263 1270
51. M.L. Iruela-Arispe, P. Hasselaar, and H. Sage Differential expression of extracellular proteins is correlated with angiogenesis in vitro Lab. Invest. 64 1991 174 186
52. H.T. Aro, B.W. Wippermann, S.F. Hodgson, and E.Y. Chao Internal remodeling of periosteal new bone during fracture healing J. Orthop. Res. 8 1990 238 246
53. M. Nagashima, A. Sakai, S. Uchida, S. Tanaka, M. Tanaka, and T. Nakamura Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur Bone 36 2005 502 511
54. V.-V. Välimäki, J.J. Yrjans, E. Vuorio, and H.T. Aro Combined effect of BMP-2 gene transfer and bioactive glass microspheres on enhancement of new bone formation J. Biomed. Mater. Res. 75 2005 501 509
55. B. Rafiee, N. Inoue, K. Jones, L. Deitz, H.T. Aro, and E.Y. Chao Trabecular microstructure in the early stage of cortical defect repair Orthopaedic Research Society, 46th Annual Meeting Transactions vol. 25 2000
56. M.C. van der Meulen, K.J. Jepsen, and B. Mikic Understanding bone strength: size isn't everything Bone 29 2001 101 104
57. J. Homminga, B.R. McCreadie, T.E. Ciarelli, H. Weinans, S.A. Goldstein, and R. Huiskes Cancellous bone mechanical properties from normals and patients with hip fractures differ on the structure level, not on the bone hard tissue level Bone 30 2002 759 764
58. D.B. Burr The contribution of the organic matrix to bone's material properties Bone 31 2002 8 11
59. D. Burr Microdamage and bone strength Osteoporos. Int. 14 2003 S67 S72
60. S.K. Volkman, A.T. Galecki, D.T. Burke, R.A. Miller, and S.A. Goldstein Quantitative trait loci that modulate femoral mechanical properties in a genetically heterogeneous mouse population J. Bone Miner. Res. 19 2004 1497 1505
61. T.A. Einhorn Clinical applications of recombinant human BMPs: early experience and future development J. Bone Jt. Surg. Am. 85 2003 S82 S88